Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection

doi:10.4254/wjh.v6.i9.652

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7916)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

318

WORD

236

HTML

3048

Figures (1-2)

219

Tables (1-3)

234

Sum=4055

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

549

Download

897

Sum=1446

Publishing Process of This Article

Item

Count

Browse

1110

Download

1305

Sum=2415

Sep 27, 2014 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Sep 27, 2014; 6(9): 652-659
Published online Sep 27, 2014. doi: 10.4254/wjh.v6.i9.652

Open in New Tab Full Size Figure Download Figure

Figure 1 Bubble plot of recurrence-free survival in patients receiving nucleos(t)ide analogue therapy or not after radical resection to treat hepatitis B virus-related hepatocellular carcinoma. Bubble size reflects relative cohort size. ^aP < 0.05: NA group vs Control group. NA: Nucleos(t)ide analogue.

Open in New Tab Full Size Figure Download Figure

Figure 2 Bubble plot of overall survival in patients receiving nucleos(t)ide analogue therapy or not after radical resection to treat hepatitis B virus-related hepatocellular carcinoma. Bubble size reflects relative cohort size. ^aP < 0.05: NA group vs Control group. NA: Nucleos(t)ide analogue.

Citation: Ke Y, Wang L, Li LQ, Zhong JH. Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection. World J Hepatol 2014; 6(9): 652-659
URL: https://www.wjgnet.com/1948-5182/full/v6/i9/652.htm
DOI: https://dx.doi.org/10.4254/wjh.v6.i9.652